ConductScience.org, home

Paper1687367

The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.

Riva E and 2 others. Br J Pharmacol, 1991. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers. Papers, record 1687367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1687367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
PubMed
Journal
Br J Pharmacol
PubMed
Year
1991
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
0.71
iCite
Revised in PubMed
2019-05-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Riva EE
2Mennini TT
3Latini RR

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic alpha-AntagonistsMajor topic
Adrenergic beta-AntagonistsMajor topic
LabetalolMajor topic
Animals
Blood Pressure
Cerebral Cortex
Dose-Response Relationship, Drug
Heart
Heart Rate
In Vitro Techniques
Isoproterenol
Male
Myocardium
Phenylephrine
Prazosin
Propranolol
Rats
Receptors, Adrenergic, alpha
Receptors, Adrenergic, beta
Stereoisomerism

Source PubMed

Download CSV of topics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12184002Dilevalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension.Drugs1990https://conductscience.org/library/papers/2184002PubMed
24202581Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.Biochem Pharmacol1973https://conductscience.org/library/papers/4202581PubMed
36114171Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.J Pharmacol Exp Ther1981https://conductscience.org/library/papers/6114171PubMed
46127131The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues.Br J Pharmacol1982https://conductscience.org/library/papers/6127131PubMed
56641087Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers.Clin Pharmacol Ther1983https://conductscience.org/library/papers/6641087PubMed
66244033Cardiac beta-adrenoceptors during normal growth of male and female rats.Br J Pharmacol1980https://conductscience.org/library/papers/6244033PubMed
77067421SPBS: statistical programs for biological sciences. Minicomputer software for applying routine biostatistical methods.Comput Programs Biomed1982https://conductscience.org/library/papers/7067421PubMed
87252843Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol.J Pharmacol Exp Ther1981https://conductscience.org/library/papers/7252843PubMed
9461970Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique.Res Commun Chem Pathol Pharmacol1979https://conductscience.org/library/papers/461970PubMed
1037098Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors.Eur J Pharmacol1979https://conductscience.org/library/papers/37098PubMed
1110948A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.Br J Clin Pharmacol1976https://conductscience.org/library/papers/10948PubMed
12686171Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.Am J Physiol1978https://conductscience.org/library/papers/686171PubMed
13990152Metabolism of labetalol by animals and man.Br J Clin Pharmacol1976https://conductscience.org/library/papers/990152PubMed
144382677A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat.Br J Pharmacol Chemother1967https://conductscience.org/library/papers/4382677PubMed
152900302Biochemical characterization of a new highly cardioselective beta-adrenoceptor antagonist.J Pharm Pharmacol1988https://conductscience.org/library/papers/2900302PubMed
163905334Importance of drug enantiomers in clinical pharmacology.Drugs1985https://conductscience.org/library/papers/3905334PubMed
172658529Dilevalol compared with propranolol and placebo for systemic hypertension.Am J Cardiol1989https://conductscience.org/library/papers/2658529PubMed
187724Alpha-noradrenergic receptor binding in mammalian brain: differential labeling of agonist and antagonist states.Life Sci1976https://conductscience.org/library/papers/7724PubMed
196687854NL-FIT: a microcomputer program for non-linear fitting.Comput Programs Biomed1983https://conductscience.org/library/papers/6687854PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
40283622Pharmacokinetic Characterization of Labetalol in Pregnancy (The CLIP Study): A Prospective Observational Longitudinal Pharmacokinetic/Pharmacodynamic Cohort Study During Pregnancy and Postpartum.J Clin Med2025https://conductscience.org/library/papers/40283622PubMed
32709242Retrospective evaluation of labetalol as antihypertensive agent in dogs.BMC Vet Res2020https://conductscience.org/library/papers/32709242PubMed
32466499Beta-Blockers and Cancer: Where Are We?Pharmaceuticals (Basel)2020https://conductscience.org/library/papers/32466499PubMed
29535162Screening for Biologically Annotated Drugs That Trigger Triacylglycerol Accumulation in the Diatom Phaeodactylum.Plant Physiol2018https://conductscience.org/library/papers/29535162PubMed
26136480The sympathetic nervous system is controlled by transient receptor potential vanilloid 1 in the regulation of body temperature.FASEB J2015https://conductscience.org/library/papers/26136480PubMed
7684671An overview of the pharmacodynamic properties and therapeutic potential of combined alpha- and beta-adrenoceptor antagonists.Drugs1993https://conductscience.org/library/papers/7684671PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1687367

GET https://conductscience.org/api/papers/v1/1687367/authors